Ruey-min Lee, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

University Of Utah School Of Medicine - Salt Lake City UT
Rank: Assistant Professor
Years: 2000-2006

Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Assistant Professor
Years: 2006-2009

None Reported

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.
Lancet Oncology
Volume: 15
Date: 01 2015

Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma.
J Hepatol.
Volume: 65
Date: 08 2016

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
Cancer Chemother Pharmacol.
Volume: 79
Date: 02 2017

Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab.
Oncotarget
Volume: 9
Date: 01 2018